PM
PathCision Medicine, Inc.
SEC filingBiotechnology · Watertown, MA
Amount raised$1.7Msold at filing
Total offering$3M$1.3M still open
Investors in the raise8count reported to the SEC
FiledFeb 5, 2026first sale Nov 10, 2022
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Hui-Hsuan WangExecutive Officer, Director
Yang LeeExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.